Perfluoroalkyl acids and related chemistries--toxicokinetics and modes of action.
暂无分享,去创建一个
Melvin E Andersen | Jennifer Seed | Gerald L Kennedy | Geary W Olsen | M. Andersen | C. Lau | J. Seed | G. Olsen | J. Butenhoff | G. Kennedy | K. Wallace | Christopher Lau | Shu-Ching Chang | John L Butenhoff | Kendall B Wallace | David G Farrar | D. Farrar | Shu-ching Chang
[1] N. Kudo,et al. Sex hormone-regulated renal transport of perfluorooctanoic acid. , 2002, Chemico-biological interactions.
[2] Mark R Cullen,et al. Longitudinal Study of Serum Lipids and Liver Enzymes in Workers With Occupational Exposure to Ammonium Perfluorooctanoate , 2007, Journal of occupational and environmental medicine.
[3] N. Kudo,et al. Induction by perfluorinated fatty acids with different carbon chain length of peroxisomal beta-oxidation in the liver of rats. , 2000, Chemico-biological interactions.
[4] Geary W Olsen,et al. Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals. , 2007, Environmental research.
[5] R. G. York,et al. Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. , 2005, Toxicology.
[6] J. Ward,et al. Diminished Hepatocellular Proliferation in Mice Humanized for the Nuclear Receptor Peroxisome Proliferator-Activated Receptor α , 2004, Cancer Research.
[7] Geary W Olsen,et al. Preliminary evidence of a decline in perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations in American Red Cross blood donors. , 2007, Chemosphere.
[8] P. Hinderliter,et al. Pharmacokinetics of perfluorooctanoate in cynomolgus monkeys. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[9] K. Hansen,et al. Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices. , 2001, Environmental science & technology.
[10] N. Kudo,et al. Rat Organic Anion Transporter 3 and Organic Anion Transporting Polypeptide 1 Mediate Perfluorooctanoic Acid Transport , 2007 .
[11] Gerald L Kennedy,et al. The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. , 2004, Toxicology.
[12] M S Christian,et al. Rat and rabbit oral developmental toxicology studies with two perfluorinated compounds. , 2001, International journal of toxicology.
[13] A. Calafat,et al. Polyfluoroalkyl Chemicals in the U.S. Population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003–2004 and Comparisons with NHANES 1999–2000 , 2007, Environmental health perspectives.
[14] Yoichi Kawashima,et al. Comparison of the toxicokinetics between perfluorocarboxylic acids with different carbon chain length. , 2003, Toxicology.
[15] J. Depierre,et al. Effects of peroxisome proliferators on the thymus and spleen of mice , 2000, Clinical and experimental immunology.
[16] N. Kudo,et al. Comparison of the elimination between perfluorinated fatty acids with different carbon chain length in rats. , 2001, Chemico-biological interactions.
[17] A. Calafat,et al. Serum concentrations of 11 polyfluoroalkyl compounds in the u.s. population: data from the national health and nutrition examination survey (NHANES). , 2007, Environmental science & technology.
[18] M E Andersen,et al. Regional hepatic CYP1A1 and CYP1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin evaluated with a multicompartment geometric model of hepatic zonation. , 1997, Toxicology and applied pharmacology.
[19] Geary W Olsen,et al. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers , 2007, International archives of occupational and environmental health.
[20] M. Stanton,et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[21] J. Giesy,et al. Global distribution of perfluorooctane sulfonate in wildlife. , 2001, Environmental science & technology.
[22] Yoichi Kawashima,et al. Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. , 2003, The Journal of toxicological sciences.
[23] Christopher S Lau,et al. Prenatal window of susceptibility to perfluorooctane sulfonate-induced neonatal mortality in the Sprague-Dawley rat. , 2003, Birth defects research. Part B, Developmental and reproductive toxicology.
[24] J M Rogers,et al. Effects of prenatal perfluorooctane sulfonate (PFOS) exposure on lung maturation in the perinatal rat. , 2005, Birth defects research. Part B, Developmental and reproductive toxicology.
[25] C. Lau,et al. Perfluoroalkyl acids: a review of monitoring and toxicological findings. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[26] Roger G Perkins,et al. The Toxicology of Perfluorooctanoate , 2004, Critical reviews in toxicology.
[27] Rolf U Halden,et al. Determinants of fetal exposure to polyfluoroalkyl compounds in Baltimore, Maryland. , 2007, Environmental science & technology.
[28] John W. Froehlich,et al. Half-Life of Serum Elimination of Perfluorooctanesulfonate,Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production Workers , 2007, Environmental health perspectives.
[29] D. Taves,et al. Evidence that there are Two Forms of Fluoride in Human Serum , 1968, Nature.
[30] M. Rosen,et al. Gene expression profiling in the lung and liver of PFOA-exposed mouse fetuses. , 2007, Toxicology.
[31] Jonathan A C Sterne,et al. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study. , 2007, American journal of epidemiology.
[32] C. Lau,et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[33] J. M. Symons,et al. Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers. , 2008, Annals of epidemiology.
[34] John P. Vanden Heuvel,et al. Differential Activation of Nuclear Receptors by Perfluorinated Fatty Acid Analogs and Natural Fatty Acids: A Comparison of Human, Mouse, and Rat Peroxisome Proliferator-Activated Receptor-α, -β, and -γ, Liver X Receptor-β, and Retinoid X Receptor-α , 2006 .
[35] R. G. York,et al. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters. , 2005, Toxicology.
[36] C. Lau,et al. Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[37] A. Calafat,et al. Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[38] Jørn Olsen,et al. Perfluorinated Chemicals and Fetal Growth: A Study within the Danish National Birth Cohort , 2007, Environmental health perspectives.
[39] L. Shaw,et al. Community Exposure to Perfluorooctanoate: Relationships Between Serum Levels and Certain Health Parameters , 2006, Journal of occupational and environmental medicine.
[40] James E Klaunig,et al. PPARalpha agonist-induced rodent tumors: modes of action and human relevance. , 2003, Critical reviews in toxicology.
[41] Jeffrey H Mandel,et al. Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. , 2003, Environmental health perspectives.
[42] K. Morimura,et al. Peroxisome Proliferator-Activated Receptor α Regulates a MicroRNA-Mediated Signaling Cascade Responsible for Hepatocellular Proliferation , 2007, Molecular and Cellular Biology.
[43] Qian Yang,et al. Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. , 2002, International immunopharmacology.
[44] J. Ward,et al. Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis. , 2006, Carcinogenesis.
[45] Rolf U. Halden,et al. Cord Serum Concentrations of Perfluorooctane Sulfonate (PFOS) and Perfluorooctanoate (PFOA) in Relation to Weight and Size at Birth , 2007, Environmental health perspectives.
[46] John W Green,et al. Cross-Sectional Study of Lipids and Liver Enzymes Related to a Serum Biomarker of Exposure (ammonium perfluorooctanoate or APFO) as Part of a General Health Survey in a Cohort of Occupationally Exposed Workers , 2007, Journal of occupational and environmental medicine.
[47] C. Lau,et al. The developmental toxicity of perfluoroalkyl acids and their derivatives. , 2004, Toxicology and applied pharmacology.
[48] Yoichi Kawashima,et al. Responses of the liver to perfluorinated fatty acids with different carbon chain length in male and female mice:in relation to induction of hepatomegaly, peroxisomal beta-oxidation and microsomal 1-acylglycerophosphocholine acyltransferase. , 2006, Biological & pharmaceutical bulletin.
[49] M. Beckmann,et al. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study , 2007, International archives of occupational and environmental health.
[50] Bruce H Alexander,et al. Self-Reported Medical Conditions in Perfluorooctanesulfonyl Fluoride Manufacturing Workers , 2007, Journal of occupational and environmental medicine.
[51] Yoichi Kawashima,et al. Tissue distribution and hepatic subcellular distribution of perfluorooctanoic acid at low dose are different from those at high dose in rats. , 2007, Biological & pharmaceutical bulletin.
[52] Harvey J Clewell,et al. Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys--probing the determinants of long plasma half-lives. , 2006, Toxicology.
[53] C. Lau,et al. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[54] Qian Yang,et al. Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice. , 2002, Biochemical pharmacology.
[55] B H Alexander,et al. Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility , 2003, Occupational and environmental medicine.
[56] David Y. Lai,et al. PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance , 2003 .
[57] James E Klaunig,et al. The Human Relevance of Information on Carcinogenic Modes of Action: Overview , 2003, Critical reviews in toxicology.
[58] G. Kennedy,et al. Absorption, Distribution, and Excretion of Ammonium Perfluorooctanoate (APFO) After Oral Administration to Various Species , 2006, Drug and chemical toxicology.
[59] Jeffrey H Mandel,et al. An occupational exposure assessment of a perfluorooctanesulfonyl fluoride production site: biomonitoring. , 2003, AIHA journal : a journal for the science of occupational and environmental health and safety.
[60] L. Shaw,et al. Community Exposure to Perfluorooctanoate: Relationships Between Serum Concentrations and Exposure Sources , 2006, Journal of occupational and environmental medicine.